Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03852147
Other study ID # PI2018_843_0014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 26, 2018
Est. completion date January 26, 2023

Study information

Verified date February 2023
Source Centre Hospitalier Universitaire, Amiens
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The measurement of the inspired / expired fractions in O2 and CO2 is part of the daily monitoring of the intubated-ventilated patient in the operating theater. The ratio of VCO2 to VO2 (respiratory quotient (RQ)) is a non-invasive indirect measure of anaerobic metabolism of the patient, and an indirect reflection of tissue perfusion. We hypothesize that a hemodynamic optimization in major surgery individualized by non-invasive continuous measurement of the RQ would optimize TaO2 more specifically by informing us about the installation of a VO2 dependence, and therefore of an anaerobic metabolism. Patients are randomized in 2 groups : Control group: hemodynamic management of patients is done according to usual practices by maintenance of blood pressure by norepinephrine as well as optimization of Systolic Voume (SV) by vascular filling and use of dobutamine if necessary. Experimental group: perioperative hemodynamic management is based on an algorithm that includes RQ measurement and includes volume expansion, norepinephrine, FiO2 enhancement, RBC transfusion and dobutamine. Primary and secondary outcomes are recorded 1,2,7 and 30 days after the surgery.


Description:

• Background : The measurement of the inspired / expired fractions in O2 and CO2 is part of the daily monitoring of the intubated-ventilated patient in the operating theater. Changes in EtCO2 may reflect changes in metabolic CO2 production (VCO2), and oxygen extraction from the body (SvO2). The inspired / exhaled oxygen difference is an indirect reflection of the oxygen consumption (VO2). The ratio of VCO2 to VO2 (respiratory quotient (RQ)) is a non-invasive indirect measure of anaerobic metabolism of the patient, and an indirect reflection of tissue perfusion. Some studies, including a recent one carried out by our center, showed that the RQ was linked to the appearance of anaerobic metabolism and to the postoperative evolution of the patient. The RQ was correlated with arterial lactate levels and predicted the occurrence of postoperative complications. Thus, the RQ can be a reliable, continuous, non-invasive marker of anaerobic metabolism in the operating room and therefore of the adequacy of arterial oxygen Transport (TaO2) with respect to the VO2 of the patient - Purpose : Th investigators hypothesize that a hemodynamic optimization in major surgery individualized by non-invasive continuous measurement of the RQ would optimize TaO2 more specifically by informing us about the installation of a VO2 dependence, and therefore of an anaerobic metabolism. - Brief summary: The measurement of the inspired / expired fractions in O2 and CO2 is part of the daily monitoring of the intubated-ventilated patient in the operating theater. The ratio of VCO2 to VO2 (respiratory quotient (RQ)) is a non-invasive indirect measure of anaerobic metabolism of the patient, and an indirect reflection of tissue perfusion. We hypothesize that a hemodynamic optimization in major surgery individualized by non-invasive continuous measurement of the RQ would optimize TaO2 more specifically by informing us about the installation of a VO2 dependence, and therefore of an anaerobic metabolism. Patients are randomized in 2 groups : Control group: hemodynamic management of patients is done according to usual practices by maintenance of blood pressure by norepinephrine as well as optimization of Systolic Voume (SV) by vascular filling and use of dobutamine if necessary. Experimental group: perioperative hemodynamic management is based on an algorithm that includes RQ measurement and includes volume expansion, norepinephrine, FiO2 enhancement, RBC transfusion and dobutamine. Primary and secondary outcomes are recorded 1,2,7 and 30 days after the surgery. Number of groups and description of groups : 2 groups Control group: hemodynamic management of patients is done according to usual practices by maintenance of blood pressure by norepinephrine as well as optimization of SV by vascular filling and use of dobutamine if necessary. Experimental group: perioperative hemodynamic management is based on an algorithm that includes RQ measurement and includes volume expansion, norepinephrine, FiO2 enhancement, RBC transfusion and dobutamine. • Interventions : Control group: hemodynamic management of patients is done according to usual practices by maintenance of blood pressure by norepinephrine as well as optimization of SV by vascular filling and use of dobutamine if necessary. Experimental group: perioperative hemodynamic management is based on an algorithm that includes RQ measurement and includes volume expansion, norepinephrine, FiO2 enhancement, RBC transfusion and dobutamine. The primary outcome is defined by at least one organ failure within 7 days postoperatively. The duration of participation of each patient is 30 days and total research term is 49 months - Number of subjects : 350 - Statistical analysis : The null hypothesis will be rejected in favor of the alternative hypothesis (there is a difference) using a test of χ2 or a Fisher test according to the frequency of the complications with a risk of the first bilateral species of 5%. - Key-words : respiratory quotient, post opérative complications, anaerobic metabolism.


Recruitment information / eligibility

Status Completed
Enrollment 350
Est. completion date January 26, 2023
Est. primary completion date December 26, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Abdominal, orthopedic or vascular surgery with general anesthesia - ASA score = II - Estimated duration of surgery> 2 hours - Consent signed. - Affiliation to a social security scheme Exclusion Criteria: - Untreated or unbalanced severe hypertension under treatment. - Preoperative renal failure dialyzed. - Acute heart failure. - Acute coronary insufficiency. - Vascular surgery with kidney plasty. - Cardiac surgery. - Permanent laparoscopy. - Preoperative shock state. - Refusal of patient's participation - Pregnant woman, parturient or breastfeeding. - Patient under guardianship or trusteeship, under the protection of justice or private public law. - Anesthesia with loco-regional anesthesia (spinal anesthesia and epidural). - Acute respiratory distress syndrome (PaO2 / FiO2 ratio <300). - Chronic Respiratory Failure with Home Oxygen Therapy. - Patient already included in another therapeutic trial with an experimental molecule. - Emergency anesthesia

Study Design


Intervention

Procedure:
: hemodynamic management
Control group: hemodynamic management of patients is done according to usual practices by maintenance of blood pressure by norepinephrine as well as optimization of SV by vascular filling and use of dobutamine if necessary. Experimental group: perioperative hemodynamic management is based on an algorithm that includes RQ measurement and includes volume expansion, norepinephrine, FiO2 enhancement, RBC transfusion and dobutamine.

Locations

Country Name City State
France BAR Amiens

Sponsors (4)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens Centre Hospitalier Universitaire de Caen, Centre Hospitalier VALENCIENNES, st isabelle health center, abbeville

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary organ failure at least one organ failure within 7 days postoperatively. • Organ failure is defined according to the recommendations of the European Anesthesia Society (ESA) and the European Resuscitation Society (ESICM). 7 days postoperatively
Primary mortality rate at day 30 30 days
Secondary the length of stay in the hospital 30 days
Secondary the SOFA score at day1 The sequential organ failure assessment score (SOFA score), previously known as the sepsis-related organ failure assessment score, is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure. The SOFA scoring system is useful in predicting the clinical outcomes of critically ill patients.According to an observational study at an Intensive Care Unit (ICU) in Belgium, the mortality rate is at least 50% when the score is increased, regardless of initial score, in the first 96 hours of admission, 27% to 35% if the score remains unchanged, and less than 27% if the score is reduced. Score ranges from 0 (best) to 24 (worst) points. 1 day
Secondary the SOFA score at day2 The sequential organ failure assessment score (SOFA score), previously known as the sepsis-related organ failure assessment score, is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure. The SOFA scoring system is useful in predicting the clinical outcomes of critically ill patients.According to an observational study at an Intensive Care Unit (ICU) in Belgium, the mortality rate is at least 50% when the score is increased, regardless of initial score, in the first 96 hours of admission, 27% to 35% if the score remains unchanged, and less than 27% if the score is reduced. Score ranges from 0 (best) to 24 (worst) points. 2 days
Secondary the SOFA score at day7 The sequential organ failure assessment score (SOFA score), previously known as the sepsis-related organ failure assessment score, is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure. The SOFA scoring system is useful in predicting the clinical outcomes of critically ill patients.According to an observational study at an Intensive Care Unit (ICU) in Belgium, the mortality rate is at least 50% when the score is increased, regardless of initial score, in the first 96 hours of admission, 27% to 35% if the score remains unchanged, and less than 27% if the score is reduced. Score ranges from 0 (best) to 24 (worst) points. 7 days
Secondary total volume of fluid intraoperatively 30 days
Secondary Plasma creatinine measured on day 0, day 1, day 2 and day 7 postoperatively 7 days
Secondary Plasma lactate measured on day 1, day 2 and day 7 postoperatively 7 days
Secondary C Reactive protein measured on day1, day2 and day7 postoperative 7 days
Secondary Troponin Tc measured on day1, day2 and day7 postoperatively 7 days
Secondary (NT pro) Brain Natriuretic Peptide ((NT pro) BNP) measured at day1, day2 and day7 postoperative 7 days
Secondary the incidence of each complication 30 days
See also
  Status Clinical Trial Phase
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Recruiting NCT04084938 - Artery Embolization vs Operation of Benign Prostate Hyperplasia N/A
Enrolling by invitation NCT03922737 - Telehealth Following Orthopaedic Procedures N/A
Not yet recruiting NCT05248139 - Safety and Effectiveness of Drop-free Small Incision Cataract Surgery N/A
Completed NCT05596552 - Comparison of Intrathecal Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine on Post-operative Urinary Retention in Knee Joint Arthroscopic Surgeries Phase 4
Not yet recruiting NCT04509986 - GlobalSurg-CovidSurg Week
Completed NCT04082598 - Antibiotic Therapy in Erupted Tooth Extractions Phase 4
Completed NCT04168307 - Physiotherapy Versus Use of a New Ankle Trainer Device After Ankle Fracture Operation. N/A
Recruiting NCT02980770 - Postoperative Complications in Patients With Obesity Hypoventilation Syndrome N/A
Recruiting NCT03323619 - Impact of Anesthesia Technique on Post-operative Delirium After Transcatheter Aortic Valve Implantation
Completed NCT04268576 - Impact of an Improved Rehabilitation Program After a Scheduled Hysterectomy.
Completed NCT04620850 - Effect of Acupressure on Recovery of Bowel Function in Patients Post Cesarean Section N/A
Completed NCT05592145 - Quantifying the Venous Congestion Curve of a Tissue Oximetry Device N/A
Completed NCT03192917 - Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy N/A
Completed NCT03036072 - Delayed Rewarming for Neuroprotection in Infants Following Cardiopulmonary Bypass Surgery N/A
Completed NCT03230474 - a Small Dose of Naloxone,Minimize Intrathecal Morphine Side Effects N/A
Recruiting NCT05269368 - Interest of Wicking for Ossicular Surgery and Myringoplasty N/A
Completed NCT04301232 - Fast-Track Eligibility and Hospital Discharge for Outpatient Lumbar Discectomy
Completed NCT04700995 - Postoperative Pain After Using NiTi Instruments N/A
Recruiting NCT06050551 - Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery N/A